Delivery Order SPE2DB24D1205-SPE2DB24FCQQE
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $4,580.34 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. This contract is for the supply of 4564658894 ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, with a completion date of May 21, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive...
- The U.S. Defense Logistics Agency (DLA) has awarded a Delivery Order contract worth $12,949.35 to Amerisourcebergen Drug Corp's Corporate Office Division to supply 4,564,857,521 units of the ADVAIR HFA 230-21 MCG INHALER 12GM pharmaceutical product. This is a firm fixed-price contract with a completion date of June 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, is leveraging its extensive supply chain capabilities to fulfill this order for the DLA, which supports the...
- The U.S. Defense Logistics Agency (DLA) awarded a $11,234.68 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM. The contract has an ultimate completion date of April 29, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA)...
- The Defense Logistics Agency (DLA) awarded a $2,981.79 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,325.24 to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $16,844.93 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ADVAIR HFA 115-21 MCG INHALER 12GM pharmaceuticals. This delivery order was issued under an existing indefinite delivery contract (IDC) worth up to $999,999,999.00 held by Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,012.09 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of ADVAIR HFA 45-21 MCG INHALER 12GM, a pharmaceutical product, with a completion date of May 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. The IDC enables DLA...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $10,256.89 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ADVAIR HFA 115-21 MCG INHALER 12GM. The contract has a completion date of January 30, 2024 and was awarded on January 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $17,666.38 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM. The delivery order was issued under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,267.12 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp's Corporate Office Division to provide ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, with a completion date of May 30, 2024. This award is under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB24FCQQEDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a $58,272.74 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of 4564322162 ADVAIR HFA 230-21 MCG INHALER 12GM, with a period of performance through April 19, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award was not set aside for any socioeconomic program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $58.3k | 4/18/24 |